Close Menu

intellectual property

Title: System for Targeted Delivery of Therapeutic Agents
Patent Number: 8,709,483
Filed: Sept. 26, 2008

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Friday that it is suing Ariosa Diagnostics for alleged patent infringement.

NEW YORK (GenomeWeb News) – Sequenom said in a regulatory filing today that the US Patent and Trademark Office, Patent Trial and Appeal Board has made rulings favorable to the company in an ongoing dispute with Verinata Health regarding noninvasive prenatal testing technologies.

Title: MADS Gene Regulatory Sequences for Expressing Gene Products in Plant Reproductive Tissue
Patent Number: 8,679,844

Title: Determinants of Sensitivity to Chemotherapeutic Agents
Patent Number: 8,673,869
Filed: Dec. 14, 2005

Title: Bacterially Derived Intact Minicells That Encompass Plasmid-free Functional Nucleic Acid for In Vivo Delivery to Mammalian Cells

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection
Patent Number: 8,664,188
Filed: Dec. 11, 2009

Title: Polyconjugates for In Vivo Delivery of Polynucleotides
Patent Number: 8,658,211
Filed: Feb. 8, 2012

Title: Prevention of Chlamydia Infection using siRNA
Patent Number: 8,648,052
Filed: Oct. 8, 2007

Title: Lipid-containing Formulations
Patent Number: 8,642,076
Filed: Aug. 16, 2011

Pages

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.